AviadoBio Ltd. ("AviadoBio") and Apertura Gene Therapy ("Apertura"), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced four presentations of new preclinical data at the ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene W ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...
A new research paper was published in Volume 18 of Aging-US on March 30, 2026, titled “A manually curated gene–phenotype ...
In complex diseases, many different genetic changes can push cells into the same harmful state, as is the case with melanoma ...
The physical differences between men and women are all too obvious, but the biological divide goes right down to the cellular ...
Investigators led by Northwestern Medicine scientists have identified mutations in a gene coding for a key ion channel in the ...
3don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Scientists in Shanghai have identified a "brake" gene that could potentially halt the progression of Alzheimer's disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results